| FDA Continues to Prioritize Compounding Regulation with the 2018Compounding Policy Priorities ...
A component of the Federal Food, Drug and Cosmetic Act (FD&C Act) is the restrictions it places on compounding drugs that are essentially copies of FDA-approved or commercially available products. On January 19, 2018, FDA issued two final guidance documents regarding the copies provisions for ...
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, January 26, 2018
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment